{"organizations": [], "uuid": "3455705cda76badd5f19c895c3475bd88ddbcf6b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-basilea-starts-clinical-phase-1-st/brief-basilea-starts-clinical-phase-1-study-in-collaboration-with-u-s-adult-brain-tumor-consortium-idUSFWN1OX0Q2", "country": "US", "domain_rank": 408, "title": "BRIEF-Basilea starts clinical phase 1 study in collaboration with U.S. Adult Brain Tumor Consortium ​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T08:20:00.000+02:00", "replies_count": 0, "uuid": "3455705cda76badd5f19c895c3475bd88ddbcf6b"}, "author": "", "url": "https://www.reuters.com/article/brief-basilea-starts-clinical-phase-1-st/brief-basilea-starts-clinical-phase-1-study-in-collaboration-with-u-s-adult-brain-tumor-consortium-idUSFWN1OX0Q2", "ord_in_thread": 0, "title": "BRIEF-Basilea starts clinical phase 1 study in collaboration with U.S. Adult Brain Tumor Consortium ​", "locations": [], "entities": {"persons": [{"name": "basilea pharmaceutica ag", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "u.s. adult brain tumor consortium ​ reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 3, 2018 / 6:22 AM / Updated 9 minutes ago BRIEF-Basilea starts clinical phase 1 study in collaboration with U.S. Adult Brain Tumor Consortium ​ Reuters Staff 1   Basilea Pharmaceutica Ag: \n* ‍INITIATION OF A PHASE 1 STUDY CONDUCTED UNDER ITS CLINICAL STUDY AGREEMENT WITH ADULT BRAIN TUMOR CONSORTIUM IN U.S.​ \n* ‍BASILEA EXPECTS TO COMPLETE PHASE 1 PATIENT RECRUITMENT INTO SEPARATE GLIOBLASTOMA ARM OF ORAL STUDY IN FIRST HALF OF 2018​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-03T08:20:00.000+02:00", "crawled": "2018-01-03T08:34:35.035+02:00", "highlightTitle": ""}